top of page

ACI Monthly (August 2024)

August 2024 Volume 1, Issue 8 Inside this issue &J’s Proposed Rebate Program DCSCA Complications State bill updates AbbVie Restricts...

ACI Monthly (June 2024)

June 2024 Volume 1, Issue 6 Inside this issue Sobi policy announcement Bausch & Lomb announcement Vertex announcement Other manufacturer...

ACI Monthly (May 2024)

May 2024 Volume 1, Issue 5 Inside this issue Senate Proposal Current Status of State Bills to Protect Contract Pharmacy OPAIS...

ACI Monthly (April 2024)

April 2024 Volume 1, Issue 4 Inside this issue Recent Manufacturer Restriction Changes Senator Hints at Overhaul of the 340B Program...

Recent Manufacturer Restriction Updates

As of April 1st, 2024, 32 drug manufacturers have implemented various contract pharmacy restrictions for Covered Entities within the 340B...

ACI Monthly (March 2024)

March 2024 Volume 1, Issue 3 Inside this issue 31st Drug Manufacturer 30th Drug Manufacturer SUSTAIN 340B Act Benefits of Contract...

ACI Monthly (February 2024)

February 2024 Volume 1, Issue 2 Inside this issue Inflation Reduction Act State Policy Updates Consultant Benefits Special points of...

ACI Monthly (January 2024)

January 2024 Volume 1, Issue 1 Inside this issue Biogen Update Takeda Update Gilead Update Manufacturer Restrictions & their Implications...

bottom of page